KLH

Harris Williams Advises D&H United Fueling Solutions on its Sale to Wind Point Partners

Retrieved on: 
Friday, September 23, 2022

Harris Williams , a global investment bank specializing in M&A advisory services, announces it advised D&H United Fueling Solutions (D&H United), a portfolio company of KLH Capital (KLH), on its sale to Wind Point Partners (Wind Point).

Key Points: 
  • Harris Williams , a global investment bank specializing in M&A advisory services, announces it advised D&H United Fueling Solutions (D&H United), a portfolio company of KLH Capital (KLH), on its sale to Wind Point Partners (Wind Point).
  • We continue to see strong investor appetite for companies like D&H United that provide mission-critical, non-deferrable services in fragmented industries, said Graham Gillam, a director at Harris Williams.
  • Wind Point is currently investing out of Wind Point Partners X, a fund that was initiated in 2022.
  • Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

Thorpe Specialty Services Finalizes Recapitalization with KLH Capital

Retrieved on: 
Monday, August 29, 2022

HOUSTON, Aug. 29, 2022 /PRNewswire/ -- Thorpe Specialty Services ("Thorpe") is pleased to announce the completion of a recapitalization of the business by KLH Capital ("KLH") from The CapStreet Group ("CapStreet").

Key Points: 
  • HOUSTON, Aug. 29, 2022 /PRNewswire/ -- Thorpe Specialty Services ("Thorpe") is pleased to announce the completion of a recapitalization of the business by KLH Capital ("KLH") from The CapStreet Group ("CapStreet").
  • KLH's unique approach of bringing resources, expertise, capital investment, and planning for specialty services, value-added distribution, and niche manufacturing companies has proven successful again and again.
  • Thorpe Specialty Services is a leading specialty services provider in energy and industrial markets for maintenance and engineering for corrosion, refractory and scaffolding and insulation.
  • Founded in 2005, KLH Capital is a private equity firm serving lower middle-market companies in the specialty services, value-added distribution, and niche manufacturing industries.

DGAP-News: technotrans significantly increases revenue and earnings in the first 6 months of 2022

Retrieved on: 
Tuesday, August 9, 2022

The Board of Management confirms the forecast of achieving consolidated revenue between 220 and 230 million in the 2022 financial year with an EBIT margin between 5.0 % and 6.0 %.

Key Points: 
  • The Board of Management confirms the forecast of achieving consolidated revenue between 220 and 230 million in the 2022 financial year with an EBIT margin between 5.0 % and 6.0 %.
  • The technotrans Group generated consolidated revenue of 113.9million in the first half of 2022, which was 9 % up on the previous year.
  • "technotrans performed very well in the first six months of 2022 despite the difficult environment.
  • These reflect the present views of the management of technotrans SE and are based on the corresponding plans, estimates and expectations.

DGAP-News: technotrans consistently implements Future Ready 2025 strategy and significantly increases consolidated revenue and EBIT in the 2021 financial year

Retrieved on: 
Tuesday, March 15, 2022

With consolidated revenue up 10.8 % to 211.1 million, technotrans exceeded the forecast last raised in November 2021 and achieved the second-highest revenue in the company's history.

Key Points: 
  • With consolidated revenue up 10.8 % to 211.1 million, technotrans exceeded the forecast last raised in November 2021 and achieved the second-highest revenue in the company's history.
  • "In the 2021 financial year, we consistently implemented the Future Ready 2025 strategy and achieved all operational and strategic goals.
  • The technotrans Group realised consolidated revenue of 211.1 million in the 2021 financial year, up 10.8 % on the previous year of 190.5 million.
  • technotrans made enormous progress in the focus markets, which generated around 73 % of consolidated revenue, in the 2021 financial year.

DGAP-News: technotrans significantly increases consolidated revenue and doubles EBIT in a tight procurement situation

Retrieved on: 
Tuesday, November 9, 2021

Provided that the procurement situation does not worsen further, the Board of Management expects group revenue of around 207 million for the 2021 financial year.

Key Points: 
  • Provided that the procurement situation does not worsen further, the Board of Management expects group revenue of around 207 million for the 2021 financial year.
  • With procurement markets becoming increasingly tight, we achieved double-digit growth in group revenue compared to the previous year and more than doubled EBIT.
  • In the first nine months of the financial year 2021, the technotrans group posted consolidated revenue of 156.6 million.
  • "The technotrans group performed very well in the first nine months despite a tight procurement situation.

Generational Equity Advises Its Client in Recapitalization by KLH Capital

Retrieved on: 
Thursday, October 14, 2021

Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the recapitalization of its client, a precision tank & cylinder manufacturer (the Company) by KLH Capital.

Key Points: 
  • Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the recapitalization of its client, a precision tank & cylinder manufacturer (the Company) by KLH Capital.
  • Founded in 2005, KLH Capital is a private equity firm serving family- and founder-owned, lower-middle-market companies in the specialty services, value-added distribution, and niche manufacturing industries.
  • Their growth is a true testament to the vision of the team, said Chris Hart, Partner at KLH Capital.
  • Generational Equity , Generational Capital Markets (member FINRA/SIPC), Generational Wealth Advisors , Generational Consulting Group , and DealForce are part of the Generational Group , which is headquartered in Dallas and is one of the leading M&A advisory firms in North America.

Therapeutic Solutions International Reports QuadraMune™ Increases T Cell Immunity in Animal Studies

Retrieved on: 
Wednesday, December 30, 2020

OCEANSIDE, Calif., Dec. 30, 2020 /PRNewswire/ --Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data demonstrating a two-week course of QuadraMune increased immunological parameters relevant to antiviral immunity.

Key Points: 
  • OCEANSIDE, Calif., Dec. 30, 2020 /PRNewswire/ --Therapeutic Solutions International, Inc., (OTC Markets: TSOI), reported today new data demonstrating a two-week course of QuadraMune increased immunological parameters relevant to antiviral immunity.
  • In a series of experiments, the Company demonstrated that animals injected with a model antigen, keyhole limpet hemacyanin (KLH) possessed a significantly enhanced T cell response.
  • The type of T cell response that was preferentially elicited in animals taking QuadraMune was associated with interferon gamma, a protein known to inhibit viral replication.
  • Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases.

Stellar Biotechnologies to Present at BlueTech Summit

Retrieved on: 
Wednesday, October 31, 2018

LOS ANGELES, Oct. 31, 2018 /PRNewswire/ --Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy and immuno-oncology development pipelines, announced today that Stellar President and CEO Frank R. Oakes will present at the 10th Annual BlueTech Summit to be held November 5-9, 2018 in San Diego, California.

Key Points: 
  • LOS ANGELES, Oct. 31, 2018 /PRNewswire/ --Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in multiple immunotherapy and immuno-oncology development pipelines, announced today that Stellar President and CEO Frank R. Oakes will present at the 10th Annual BlueTech Summit to be held November 5-9, 2018 in San Diego, California.
  • The conference, which focuses on sustainable ocean and water technologies, is presented by The Maritime Alliance, a non-profit organizer of San Diego's BlueTech cluster and BlueTech Week .
  • Stellar is committed to meeting the growing demand for commercial-scale supplies of GMP grade KLH, ensuring environmentally sound KLH production, and supporting the development of KLH-based active immunotherapies.
  • Stellar KLH is a trademark of Stellar Biotechnologies.

Stellar Biotechnologies to Present at H. C. Wainwright Global Investment Conference

Retrieved on: 
Tuesday, August 28, 2018

Stellar senior management will be available during the conference for one-on-one meetings.

Key Points: 
  • Stellar senior management will be available during the conference for one-on-one meetings.
  • Members of the investment community who are interested in meeting with Stellar should contact conference coordinators to arrange an appointment.
  • KLH can also be used in immunotoxicology studies for monitoring the immunomodulatory effects of drug candidates.
  • Stellar KLH is a trademark of Stellar Biotechnologies.

Stellar Reports Positive Research Results from KLH Glycosylation Study

Retrieved on: 
Thursday, June 21, 2018

As part of the study, third party researchers analyzed the patterns of carbohydrates that attach to the KLH protein through a biologic process known as glycosylation.

Key Points: 
  • As part of the study, third party researchers analyzed the patterns of carbohydrates that attach to the KLH protein through a biologic process known as glycosylation.
  • Due in part to the large size and complexity of this glycosylation, KLH has never been synthesized.
  • Stellar Executive Vice President of Corporate Development, Gregory T. Baxter, PhD reported that study results demonstrated highly consistent molecular structure from batch to batch, a key attribute for a biologically sourced protein.
  • Researchers interested in obtaining Stellar KLH, or obtaining technical specifications for research or GMP-grade KLH, may contact Stellar business development department at (805)488-2800 or [email protected] .